Hartford Business Journal

August 15, 2016

Issue link: https://nebusinessmedia.uberflip.com/i/714477

Contents of this Issue

Navigation

Page 0 of 23

G R E AT E R H A R T F O R D ' S B U S I N E S S N E W S w w w. H a r t f o rd B u s i n e s s . c o m For more B2B news visit AUGUST 15, 2016 Volume 24, Number 37 $3.00 Subscribe online JOIN US! 'BLACK TIE & BLUE JEANS' ANNIVERSARY EVENT WEDNESDAY, SEPT. 14, 2016 CT CONVENTION CENTER | HARTFORD 20th ANNIVERSARY 19 9 7-2 0 1 6 Index ■ Reporter's Notebook: PG. 5 ■ Week in Review: PG. 6 ■ The List: PG. 10 ■ Deal Watch: PG. 11 ■ Town Profile: PG. 16 ■ Movers & Shakers: PG. 18 ■ Opinion & Commentary: PG. 20 FOCUS: HEALTH CARE Wary Docs A new law passed by Congress last year is changing the way doctors will be paid for treating Medicare patients, and not all Connecticut physicians are on board with the shift. PG. 8 Manufacturer Spotlight Precision Punch is among some 3,000 U.S. producers engaged in metal-stamping and fabrication, a manufacturing segment that generates an estimated $130 billion a year in sales. Find out how the Berlin company differentiates itself from the competition. PG. 3 UConn's startup interns build CT's STEM-talent pipeline By Matt Pilon mpilon@HartfordBusiness.com E arlier this month, scientists, engineers and entrepreneurs looked on as UConn under- graduate and graduate-level stu- dents presented what they accom- plished as summer interns working at the school's incubator companies in Farmington and Storrs. Hailing from more than a dozen majors — and some already with STEM-related work expe- rience under their belts — the students' projects were equally diverse, ranging from the creation of marketing plans for software Building Bioscience A N H B J S E R I E S O N C T ' S B I O S C I E N C E S E C T O R Research Pivot Scientist Guangwei Yang at work at Achillion Pharmaceuticals' New Haven laboratory-headquarters. P H O T O | C O N T R I B U T E D H artford Business Journal's series on Connecticut's bioscience industry continues this week with a look at New Haven-based Achillion Pharmaceuticals. Following its 2015 licensing agreement with Johnson & Johnson Co.'s Janssen Pharmaceuticals division for its Hepatitis C treatments, Achillion is using its $426.5 mil- lion cash horde to self-fund its latest pivot into research and development, and perhaps even- tual commercialization, of a new class of treat- ments. Find out more on PG. 12 Scott Conroy, a graduate student in applied genomics, interned for Frequency Therapeutics, which is developing a way to regrow inner ear hairs used for hearing. Continued on page 14 H B J P H O T O | M A T T P I L O N Achillion's deep pockets will fuel its next chapter

Articles in this issue

Links on this page

Archives of this issue

view archives of Hartford Business Journal - August 15, 2016